BCIRG 007: Serum HER2 levels in women with metastatic HER2-amplified breast cancer

被引：0
|
作者：
Sampson, E. L.
Valero, V.
Roche, H.
Pienkowski, T.
Canon, J.
Zhao, Y.
Carney, W.
Mackey, J.
Taupin, H.
Lindsay, M.
Buyse, M.
Slamon, D.
机构：
[1] Siemens Med Solut Diagnost, Tarrytown, NY USA
[2] Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA
[3] Inst Claudius Regaud, Toulouse, France
[4] MS Curie Mem Canc Ctr, Warsaw, Poland
[5] CH Notre Dame, Charleroi, Belgium
[6] Univ Calif Los Angeles, Los Angeles, CA USA
[7] Cross Canc Inst, Edmonton, AB T6G 1Z2, Canada
[8] CIRG, Paris, France
[9] CIRG, Edmonton, AB, Canada
[10] IDDI, Louvain, Belgium
来源：
CLINICAL CHEMISTRY | 2007年 / 53卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
A109
引用
收藏
页码：A34 / A34
页数：1
相关论文
共 50 条
  • [1] BCIRG 007: Serum HER2 levels in women with metastatic HER2-amplified breast cancer
    Valero, V.
    Roche, H.
    Pienkowski, T.
    Canon, J.
    Zhao, Y.
    Carney, W.
    Mackey, J.
    Taupin, H.
    Buyse, M.
    Slamon, D.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [2] The role of HER2 and HER3 in HER2-amplified cancers beyond breast cancers
    Avisek Majumder
    Manbir Sandhu
    Debarko Banerji
    Veronica Steri
    Adam Olshen
    Mark M. Moasser
    Scientific Reports, 11
  • [3] The role of HER2 and HER3 in HER2-amplified cancers beyond breast cancers
    Majumder, Avisek
    Sandhu, Manbir
    Banerji, Debarko
    Steri, Veronica
    Olshen, Adam
    Moasser, Mark M.
    SCIENTIFIC REPORTS, 2021, 11 (01) : 9091
  • [4] Predicting tissue HER2 status using serum HER2 levels in patients with metastatic breast cancer
    Kong, Sun-Young
    Nam, Byung-Ho
    Lee, Keun Seok
    Kwon, Youngmee
    Lee, Eun Sook
    Seong, Moon-Woo
    Lee, Do Hoon
    Ro, Jungsil
    CLINICAL CHEMISTRY, 2006, 52 (08) : 1510 - 1515
  • [5] A comprehensive appraisal of HER2 heterogeneity in HER2-amplified and HER2-low colorectal cancer
    Taiki Hashimoto
    Daisuke Takayanagi
    Junpei Yonemaru
    Tomoaki Naka
    Kengo Nagashima
    Erika Machida
    Takashi Kohno
    Yasushi Yatabe
    Yukihide Kanemitsu
    Ryuji Hamamoto
    Atsuo Takashima
    Kouya Shiraishi
    Shigeki Sekine
    British Journal of Cancer, 2023, 129 : 1176 - 1183
  • [6] A comprehensive appraisal of HER2 heterogeneity in HER2-amplified and HER2-low colorectal cancer
    Hashimoto, Taiki
    Takayanagi, Daisuke
    Yonemaru, Junpei
    Naka, Tomoaki
    Nagashima, Kengo
    Machida, Erika
    Kohno, Takashi
    Yatabe, Yasushi
    Kanemitsu, Yukihide
    Hamamoto, Ryuji
    Takashima, Atsuo
    Shiraishi, Kouya
    Sekine, Shigeki
    BRITISH JOURNAL OF CANCER, 2023, 129 (07) : 1176 - 1183
  • [7] Combined targeting of HER2 and VEGFR2 for effective treatment of HER2-amplified breast cancer brain metastases
    Kodack, David P.
    Chung, Euiheon
    Yamashita, Hiroshi
    Incio, Joao
    Duyverman, Annique M. M. J.
    Song, Youngchul
    Farrar, Christian T.
    Huang, Yuhui
    Ager, Eleanor
    Kamoun, Walid
    Goel, Shom
    Snuderl, Matija
    Lussiez, Alisha
    Hiddingh, Lotte
    Mahmood, Sidra
    Tannous, Bakhos A.
    Eichler, April F.
    Fukumura, Dai
    Engelman, Jeffrey A.
    Jain, Rakesh K.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2012, 109 (45) : E3119 - E3127
  • [8] Serum HER2 extracellular domain levels and HER2 circulating tumor cell status in patients with metastatic breast cancer
    Aurilio, Gaetano
    Sandri, Maria Teresa
    Pruneri, Giancarlo
    Zorzino, Laura
    Botteri, Edoardo
    Munzone, Elisabetta
    Adamoli, Laura
    Facchi, Giuseppina
    Cullura, Daniela
    Verri, Elena
    Rocca, Maria Cossu
    Zurrida, Stefano
    Iacovelli, Roberto
    Nole, Franco
    FUTURE ONCOLOGY, 2016, 12 (17) : 2001 - 2008
  • [9] Radiolabeled trastuzumab biodistribution and serum HER2 levels in HER2-positive metastatic breast cancer patients
    Perik, Patrick J.
    Lub-de Hogge, Marjolijn N.
    Gietema, Jourik A.
    Jager, Piet L.
    Kosterink, Jos G.
    de Korte, Sander A.
    van Veldhuisen, Drik J.
    van der Graaf, Winette T.
    Sieijfer, Drik T.
    de Vries, Elisabeth G.
    ANNALS OF ONCOLOGY, 2004, 15 : 14 - 14
  • [10] Correlation between serum HER2 extracellular domain (HER2 ECD) levels and tumour size in early, advanced and metastatic breast cancer with HER2 overexpression
    Makino, H.
    Tengan, H.
    Tatsuda, K.
    Hashidate, H.
    Mio, K.
    Kiguchi, T.
    Yamazaki, M.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : S114 - S115
12345